Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF‐β1/Smad signaling pathway
Autor: | Jinpeng Zhou, Long Li, Yang Jiang, Haiying Zhang, Ye Zhang, Peng Luo, Yin-Sheng Chen, Yanju Ma, Dianqi Hou, Zhitao Jing, Dan Zou, Huiling Gao |
---|---|
Rok vydání: | 2019 |
Předmět: |
Male
0301 basic medicine Epithelial-Mesenchymal Transition Mesenchymal Glioblastoma Mice Nude Smad Proteins SMAD Biology urologic and male genital diseases Saposins Pathology and Forensic Medicine Transforming Growth Factor beta1 03 medical and health sciences 0302 clinical medicine Cell Movement Neurotrophic factors Cell Line Tumor Glioma Biomarkers Tumor Tumor Cells Cultured medicine Animals Humans Neoplasm Invasiveness Phosphorylation Prosaposin Mice Inbred BALB C Brain Neoplasms urogenital system Mesenchymal stem cell Middle Aged medicine.disease female genital diseases and pregnancy complications nervous system diseases 030104 developmental biology 030220 oncology & carcinogenesis Neoplastic Stem Cells Cancer research Female Stem cell Glioblastoma Signal Transduction Transforming growth factor |
Zdroj: | The Journal of Pathology. 249:26-38 |
ISSN: | 1096-9896 0022-3417 |
DOI: | 10.1002/path.5278 |
Popis: | Mesenchymal glioblastoma (GBM) is the most aggressive subtype of GBM. Our previous study found that neurotrophic factor prosaposin (PSAP) is highly expressed and secreted in glioma and can promote the growth of glioma. The role of PSAP in mesenchymal GBM is still unclear. In this study, bioinformatic analysis, western blotting and RT-qPCR were used to detect the expression of PSAP in different GBM subtypes. Human glioma cell lines and patient-derived glioma stem cells were studied in vitro and in vivo, revealing that mesenchymal GBM expressed and secreted the highest level of PSAP among four subtypes of GBM, and PSAP could promote GBM invasion and epithelial-mesenchymal transition (EMT)-like processes in vivo and in vitro. Bioinformatic analysis and western blotting showed that PSAP mainly played a regulatory role in GBM invasion and EMT-like processes via the TGF-β1/Smad signaling pathway. In conclusion, the overexpression and secretion of PSAP may be an important factor causing the high invasiveness of mesenchymal GBM. PSAP is therefore a potential target for the treatment of mesenchymal GBM. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. |
Databáze: | OpenAIRE |
Externí odkaz: |